BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sacerdote P, Ruff MR, Pert CB. Cholecystokinin and the immune system: receptor-mediated chemotaxis of human and rat monocytes. Peptides. 1988;9 Suppl 1:29-34. [PMID: 2856648 DOI: 10.1016/0196-9781(88)90219-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Pivovarova O, Hornemann S, Weimer S, Lu Y, Murahovschi V, Zhuk S, Seltmann AC, Malashicheva A, Kostareva A, Kruse M, Busjahn A, Rudovich N, Pfeiffer AF. Regulation of nutrition-associated receptors in blood monocytes of normal weight and obese humans. Peptides 2015;65:12-9. [PMID: 25620618 DOI: 10.1016/j.peptides.2014.11.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
2 Schepetkin IA, Kirpotina LN, Khlebnikov AI, Jutila MA, Quinn MT. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors. Mol Pharmacol 2011;79:77-90. [PMID: 20943772 DOI: 10.1124/mol.110.068288] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
3 Cabaner C, Boudard F, Bastide M. Modulation of the Proliferative Response of Murine Peyer's Patch Lymphocytes by Different Peptides: CCK-8, CGRP, CCK-PZ and VIP. Preliminary Results. Int J Immunopathol Pharmacol 1995;8:123-33. [DOI: 10.1177/039463209500800207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Kõks S, Fernandes C, Kurrikoff K, Vasar E, Schalkwyk LC. Gene expression profiling reveals upregulation of Tlr4 receptors in Cckb receptor deficient mice. Behav Brain Res 2008;188:62-70. [PMID: 18054398 DOI: 10.1016/j.bbr.2007.10.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
5 Carrasco M, Hernanz A, De La Fuente M. Effect of cholecystokinin and gastrin on human peripheral blood lymphocyte functions, implication of cyclic AMP and interleukin 2. Regul Pept. 1997;70:135-142. [PMID: 9272625 DOI: 10.1016/s0167-0115(97)00025-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Carrasco M, Del Rio M, Hernanz A, De la Fuente M. Inhibition of human neutrophil functions by sulfated and nonsulfated cholecystokinin octapeptides. Peptides. 1997;18:415-422. [PMID: 9145430 DOI: 10.1016/s0196-9781(96)00338-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
7 Alvarez A, Ibiza MS, Andrade MM, Blas-García A, Calatayud S. Gastric antisecretory drugs induce leukocyte-endothelial cell interactions through gastrin release and activation of CCK-2 receptors. J Pharmacol Exp Ther 2007;323:406-13. [PMID: 17652263 DOI: 10.1124/jpet.107.122754] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
8 Jia X, Cong B, Zhang J, Li H, Liu W, Chang H, Dong M, Ma C. CCK8 negatively regulates the TLR9-induced activation of human peripheral blood pDCs by targeting TRAF6 signaling. Eur J Immunol 2014;44:489-99. [PMID: 24301797 DOI: 10.1002/eji.201343725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
9 Robberecht P, De Neef P, Buscail L, Christophe J. The phorbol ester TPA stimulates the expression of functional beta-adrenoceptors in human T lymphoblasts Molt 3. Biochem J 1989;261:959-63. [PMID: 2552994 DOI: 10.1042/bj2610959] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
10 De la Fuente M, Campos M, Del Rio M, Hernanz A. Inhibition of murine peritoneal macrophage functions by sulfated cholecystokinin octapeptide. Regul Pept. 1995;55:47-56. [PMID: 7724827 DOI: 10.1016/0167-0115(94)00091-b] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
11 And PS, Panerai AE. Pharmacological modulation of beta-endorphin in rat peritoneal macrophages. J Clin Lab Anal 1989;3:337-9. [DOI: 10.1002/jcla.1860030604] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
12 Meng AH, Ling YL, Zhang XP, Zhang JL. Anti-inflammatory effect of cholecystokinin and its signal transduction mechanism in endotoxic shock rat. World J Gastroenterol 2002;8:712-7. [PMID: 12174384 DOI: 10.3748/wjg.v8.i4.712] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
13 Egger M, Beer AG, Theurl M, Schgoer W, Hotter B, Tatarczyk T, Vasiljevic D, Frauscher S, Marksteiner J, Patsch JR. Monocyte migration: a novel effect and signaling pathways of catestatin. Eur J Pharmacol. 2008;598:104-111. [PMID: 18834877 DOI: 10.1016/j.ejphar.2008.09.016] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
14 Sacerdote P, Wiedermann CJ, Wahl LM, Pert CB, Ruff MR. Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen. Peptides 1991;12:167-76. [DOI: 10.1016/0196-9781(91)90184-q] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ling YL, Meng AH, Zhao XY, Shan BE, Zhang JL, Zhang XP. Effect of cholecystokinin on cytokines during endotoxic shock in rats. World J Gastroenterol 2001;7:667-71. [PMID: 11819851 DOI: 10.3748/wjg.v7.i5.667] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
16 Yang HL, Yang TY, Gowrisankar YV, Liao CH, Liao JW, Huang PJ, Hseu YC. Suppression of LPS-Induced Inflammation by Chalcone Flavokawain A through Activation of Nrf2/ARE-Mediated Antioxidant Genes and Inhibition of ROS/NFκB Signaling Pathways in Primary Splenocytes. Oxid Med Cell Longev 2020;2020:3476212. [PMID: 32617135 DOI: 10.1155/2020/3476212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
17 Weiland TJ, Kent S, Voudouris NJ, Shulkes A. The effect of lipopolysaccharide on cholecystokinin in murine plasma and tissue. Peptides 2005;26:447-55. [DOI: 10.1016/j.peptides.2004.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
18 Tang SC, Braunsteiner H, Wiedermann CJ. Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide in vitro. Immunol Lett. 1992;34:237-242. [PMID: 1283156 DOI: 10.1016/0165-2478(92)90219-e] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Alvarez A, Ibiza S, Hernández C, Alvarez-Barrientos A, Esplugues JV, Calatayud S. Gastrin induces leukocyte-endothelial cell interactions in vivo and contributes to the inflammation caused by Helicobacter pylori. FASEB J 2006;20:2396-8. [PMID: 17015411 DOI: 10.1096/fj.05-5696fje] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
20 Weiland TJ, Voudouris NJ, Kent S. CCK 2 receptor nullification attenuates lipopolysaccharide-induced sickness behavior. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2007;292:R112-23. [DOI: 10.1152/ajpregu.00156.2006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
21 Panerai AE, Radulovic J, Monastra G, Manfredi B, Locatelli L, Sacerdote P. β-Endorphin concentrations in brain areas and peritoneal macrophages in rats susceptible and resistant to experimental allergic encephalomyelitis: A possible relationship between tumor necrosis factor α and opioids in the disease. Journal of Neuroimmunology 1994;51:169-76. [DOI: 10.1016/0165-5728(94)90078-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
22 Sacerdote P, Ruff MR, Pert CB. VIP 1?12 Is a Ligand for the CD 4 /Human Immunodeficiency Virus Receptor. Ann NY Acad Sci 1988;527:574-8. [DOI: 10.1111/j.1749-6632.1988.tb27010.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
23 De la Fuente M, Carrasco M, Del Rio M, Hernanz A. Modulation of murine lymphocyte functions by sulfated cholecystokinin octapeptide. Neuropeptides. 1998;32:225-233. [PMID: 10189056 DOI: 10.1016/s0143-4179(98)90041-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
24 Cross-mellor SK, Kavaliers M, Ossenkopp K. Repeated injections of lipopolysaccharide attenuate the satiety effects of cholecystokinin: . NeuroReport 1999;10:3847-51. [DOI: 10.1097/00001756-199912160-00023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
25 Medina S, Del Rı́o M, Manuel Vı́ctor V, Hernánz A, De la Fuente M. Changes with ageing in the modulation of murine lymphocyte chemotaxis by CCK-8S, GRP and NPY. Mechanisms of Ageing and Development 1998;102:249-61. [DOI: 10.1016/s0047-6374(98)00014-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
26 Zuelli FMDGC, Cárnio EC, Saia RS. Cholecystokinin protects rats against sepsis induced by Staphylococcus aureus. Med Microbiol Immunol 2014;203:165-76. [DOI: 10.1007/s00430-014-0328-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
27 Panerai AE. Lymphocytes as a source of hormones and peptides. J Endocrinol Invest 1993;16:549-57. [DOI: 10.1007/bf03348904] [Cited by in Crossref: 10] [Article Influence: 1.4] [Reference Citation Analysis]
28 Panerai AE, Sacerdote P. Brain and gut neuropeptides in peripheral blood mononuclear cells. J Physiol Paris 1993;87:283-9. [PMID: 8298605 DOI: 10.1016/0928-4257(93)90034-q] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]